Twitter Logo Youtube Circle Icon LinkedIn Icon

Israel > Healthcare and life sciences > Law firm and leading lawyer rankings


Index of tables

  1. Healthcare and life sciences
  2. Leading individuals

Leading individuals

  1. 1

Who Represents Who

Find out which law firms are representing which Healthcare and life sciences clients in Israel using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact


Goldfarb Seligman & Co.’s healthcare and life sciences team advises domestic and international biotech and pharmaceutical companies on complex commercial agreements and strategic financing and M&A transactions. Led by Eli Zohar, the team serves as outside counsel to The Israeli Medical Association. Sharon Gazit assists foreign medical device companies with operations in Israel.

As one of Israel’s two largest firms, Herzog Fox & Neeman’s broad healthcare and life sciences department acts for a variety of healthcare-focused corporates, pharmaceutical companies, investors and physicians. Zohar Yahalom has a formidable regulatory practice, while Dan Sharot and Neta Dorfman Raviv handle commercial and partnership agreements and financing transactions.

Acting for corporates and sector-specific investors, Horn & Co has a strong reputation in the Israeli life sciences and pharmaceuticals industry. Yuval Horn has considerable experience in cross-border commercial contracts, partnership agreements, financing and M&A. Horn also represents Pontifax in all of its investment activity. Keren Kanir and Ohad Mamann are additional contacts.

Liad Whatstein & Co. Law Office demonstrates ‘broad business acumen and industry knowledge of the pharmaceutical sector in Israel and further afield’. Led by Liad Whatstein, the firm’s reputation is evinced by an impressive client roster, which includes Novartis, Sanofi, Merck, Pfizer, Eli Lilly and the State of Israel. Amira Mangelus is also recommended.

Lipa Meir & Co provides comprehensive commercial and regulatory advice to healthcare providers, medical device manufacturers and distributors, private medical centres and tech companies. Osnat Sarusi-Firstater acts for pioneering med-tech companies such as Opisoft and Circ MedTech, while Gary Copelovitz is instructed by health services giant Clalit Health Services.

M. Firon & Co Advocates and Notaries is considered by many to be ‘the best firm in Israel for pharmaceutical’ companies. Indeed, Baruch Shugol provides commercial and regulatory advice to GSK Israel and Pfizer Israel, while Niv Sever acts for Sanofi Aventis Israel and Gilead. Liora Lotenberg took an in-house position with one of the firm’s clients.

S. Horowitz & Co’s healthcare capabilities are wide ranging, covering the gamut of corporate transactions and commercial agreements, litigation and regulatory and legislative counselling, particularly in the pharmaceutical sector. Headed by Tal Band and Dovev Apel, the department acts for Teva, Maccabi Healthcare Services and The Chemical, Pharmaceutical and Environmental Society of the Manufacturers’ Association of Israel.

The team at Tadmor & Co. Yuval Levy & Co.exemplifies healthcare sector expertise’ and works with hospitals, industry associations, healthcare and pharmaceutical companies, and state-sponsored incubators. Efrat Shapira-Orren heads the department and Efrat Cohen assisted SAREL Supplies & Services for Medicine in governmental proceedings regarding services provided to the state healthcare system.

Yigal Arnon & Co is involved in many of the largest cross-border M&A in Israel’s healthcare sector. Daniel Green advises Oramed Pharmaceuticals on commercial licensing transactions and cross-border partnership agreements. Yoheved Novogroder-Shoshan and Barry Levenfeld act for biotech incubators such as FutuRx and MEDX Xelerator.

Amit, Pollak, Matalon & Co. Advocates and Notary acts for biotech start-ups, listed healthcare companies, sector-specific investors and healthcare incubators. Practice head Ian Rostowsky advised MindUp on its bid for and activation of a franchise from the Israeli National Authority for Technological Innovation.

At Barath, Pappo, Betser, Floom, Schrieber & Co. (BFP & Co.), Haleli Barath advises biotech companies on development, licensing and partnership agreements and corporate finance transactions. The team acts for industry investors such as Triventures and eHealth Ventures.

Fischer Behar Chen Well Orion & Co has extensive experience advising investment groups and Israeli hi-tech companies on financing and securities transactions. Eran Yaniv assisted MetaboMed with equity investment rounds with sophisticated investors. Raz Tepper advises investor clients.

GKH – Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co handles large financing, M&A and capital markets transactions for funds and major healthcare companies, including Edwards Lifesciences. Hili Cohen advised biotech incubators on an Israeli Innovation Authority tender for government sponsorship.

The ‘responsive and professional’ department at Katzenell Dimant has ‘excellent knowledge of the healthcare sector’ and is ‘well connected to industry players domestically and globally’. Einat Katzenell’s team advises biotech companies and sector-specific investors on commercial agreements, various corporate transactions and regulatory compliance.

Meitar Liquornik Geva Leshem Tal Law Offices is instructed by biotech, pharmaceutical and medical device companies in corporate transactions and litigation. Israel Leshem and Ron Peleg have handled high-value disputes for AstraZeneca, while David Mirchin handles commercial agreements for the client.

Pearl Cohen Zedek Latzer Baratz handles a range of IP, commercial and corporate transactional work for listed biotech companies. Hili Rashkovan has experience in global clinical trial arrangements, and Mark Cohen handles licensing and rights transactions for Immune Pharmaceuticals.

Shibolet & Co. with Raved, Magriso, Benkel & Co. advises Israeli medical companies on partnership and R&D agreements with multinational healthcare companies and also handles multijurisdictional transactions. Ofer Ben-Yehuda has assisted biotech companies involved in cross-border clinical trials. Tal Karplus and Amir Iliescu are other contacts. The legacy Shibolet firm merged with Raved, Magriso, Benkel & Co. at the end of 2017.

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to
  • Bär & Karrer Advises CEVA Logistics on its IPO, the anchor investment by CMA CGM and its migration

    CEVA Logistics, one of the world's leading third-party logistics companies, successfully priced its IPO and listed its shares on the SIX Swiss Exchange, where trading commenced on 4 May 2018. With a market capitalization of CHF 1.6 billion and generating gross proceeds of CHF 821 million, this is so far considered as the largest IPO on the SIX Swiss Exchange for 2018. In addition, CMA CGM, the third largest container shipping group in the world, has committed to make a strategic cornerstone investment in CEVA Logistics by purchasing CHF 379 million of mandatory convertible securities which will convert into shares of CEVA Logistics once certain regulatory approvals have been obtained. Simultaneously with the IPO, CEVA Holdings, the former holding company of the CEVA group, migrated from the Marshall Islands to Switzerland by way of a cross-border merger with CEVA Logistic as the surviving company.
  • BAG: Employer not liable for harm caused by vaccine

    Employers who have flu vaccines administered within their company are not liable for any harm that might occur as a result of the vaccine. That was the verdict of the Bundesarbeitsgericht (BAG), Germany’s Federal Labour Court, in a recent ruling.
  • Tax Update

    Cyprus Tax Department has announced that, as of June 1 st 2018 , the following taxes, not bearing interest and charges, can ONLY be paid via JCCsmart (website ) . JCCsmart is a Cyprus portal used to contact payments to various organizations including the Government. This measure follows the successful implementation of the Pay As You Earn (PAYE) tax withheld from employees through JCCsmart.
  • Bär & Karrer Advises on the Financing of the Largest Thermoelectric Plant in Latin America

    Centrais Elétricas de Sergipe S.A. (CELSE) has successfully issued bonds for approx. USD 1 billion equivalent in local currency at a fixed, long-term rate in international capital markets. The innovative bond issue is guaranteed by the Swiss Export Risk Insurance (SERV), the export credit agency of Switzerland. The bonds are part of a financial package to finance the development, design, construction, operation and maintenance of a thermoelectric power plant by CELSE in the state of Sergipe in the northeast region of Brazil. Besides the bond issue for approx. USD 1 billion, the transaction includes a USD 200 million loan from the International Finance Corporation and a financial package of the Inter-American Development Bank in the amount of approx. USD 300 million. Once operational expected for in 2020, CELSE will sell electricity to 26 distribution companies in Brazil, becoming the largest and most efficient thermoelectric plant in Latin America and the Caribbean.
  • BAG: Threats made by employee can justify dismissal with immediate effect

    Employers do not have to accept threats made by employees. These can constitute good cause justifying extraordinary notice of dismissal with immediate effect, as demonstrated by a ruling of the Bundesarbeitsgericht (BAG), Germany’s Federal Labour Court.
  • SyCipLaw is Tier 1 Firm in IP STARS 2018 Rankings

    SyCip Salazar Hernandez & Gatmaitan (SyCipLaw) was once again ranked by Managing IP’s IP STARS 2018 as a Tier 1 firm in Patent and Trademarks/Copyright in the Philippines. In addition, SyCipLaw partners Enrique T. Manuel and Vida M. Panganiban-Alindogan are ranked as Trade mark star – Philippines . Mr. Manuel is also ranked as Patent star – Philippines .
  • Bär & Karrer Advises on Partial Self-Tender Offer

    On 21 September 2017, an extraordinary shareholders' meeting of the SIX Swiss Exchange listed N.V. authorized the board of directors to repurchase up to 33 1/3% of the company's share capital by means of a partial self-tender offer. The resolution adopted under Dutch law contained detailed information, among others regarding the period for which the authorization is granted, the manner in which the shares are repurchased and the price range within which the offer price must be set.
  • New Serbian Law on Foreigners Adopted

    In March 2018, the new Serbian Law on Foreigners was adopted, replacing the 2008 version of this law- in force until recently without any amendments. The new law will enter into force on 3 October 2018.
  • The Serbian Law on Foreign Exchange Amended

    On 20 April 2018, the amendments to the Law on Foreign Exchange (the “Law ”) were adopted and will enter into force on 28 April 2018 . Exceptionally, the application of certain provisions related to the assuming of competencies over foreign exchange control by the National Bank of Serbia is delayed until 1 January 2019.
  • Bär & Karrer Advises Vyaire Medical on its Acquisition of Acutronic Medical Systems

    Vyaire Medical, Inc., a global leader in respiratory care, acquired all shares in the Acutronic Medical Systems group, a Switzerland and Germany-based leader in the design and manufacture of neonatal ventilation equipment.